Figure 2.
Validation of association between TNFR2 and sensitivity to birinapant in an independent cohort. (A) Expression of TNFR1 and TNFR2 from the validation cohort (n = 44), with selected patients marked in blue (high TNFR2, n = 5) and red (low TNFR2, n = 5). (B) Response to birinapant for selected patients (n = 10). (C) Birinapant IC50 values. (D) Rescue from birinapant (48 hours, 50 nM) with zVAD (25 μM) and/or Nec-1s (25 μM). All quantifications are mean ± SEM and were derived from 1 experiment in triplicate for the indicated number of primary samples.

Validation of association between TNFR2 and sensitivity to birinapant in an independent cohort. (A) Expression of TNFR1 and TNFR2 from the validation cohort (n = 44), with selected patients marked in blue (high TNFR2, n = 5) and red (low TNFR2, n = 5). (B) Response to birinapant for selected patients (n = 10). (C) Birinapant IC50 values. (D) Rescue from birinapant (48 hours, 50 nM) with zVAD (25 μM) and/or Nec-1s (25 μM). All quantifications are mean ± SEM and were derived from 1 experiment in triplicate for the indicated number of primary samples.

Close Modal

or Create an Account

Close Modal
Close Modal